Drug profile · INN
colesevelam hydrochloride
COLESEVELAM HYDROCHLORIDE
colesevelam hydrochloride (COLESEVELAM HYDROCHLORIDE) is a bile acids sequestering agent. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — colesevelam hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
colesevelam hydrochloride (COLESEVELAM HYDROCHLORIDE) is a bile acids sequestering agent. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bile acids sequestering agent
Primary target: Bile acids
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12383500
Nanoliposome compositions and methods of using the same
granted -
US 12383618
Expression vector delivery system and use thereof for inducing an immune response
granted -
US 12383554
Compositions and methods to protect mammalian tissue against cold and other metabolic stresses
granted -
US 12384820
Griffithsin mutants
granted -
US 12350274
Nucleotide analogs
granted -
US 12343432
Encapsulated probiotic
granted -
US 12336974
Methods and compositions for preventing and treating auditory dysfunctions
granted -
US 12325688
Gingerenone A prodrugs as sensotherapeutics and methods of use
granted -
US 12298315
Systems and methods to identify and treat subjects at risk for obstetrical complications
granted -
US 12286657
Methods and compositions
granted -
US 12281060
Remodilins for airway remodeling and organ fibrosis
granted -
US 12281336
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins
granted -
US 12275758
Prefusion RSV F proteins and their use
granted -
US 12269803
Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease
granted -
US 12268749
Cell-penetrating peptides
granted -
US 12239654
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 12226423
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
granted -
US 12215164
Immunotoxins with albumin binding domain
granted -
US 12214031
Mannheimia haemolytica vector
granted -
US 12210017
Peptides representing epitopes from filoviruses
granted
Frequently asked questions
What is colesevelam hydrochloride?
colesevelam hydrochloride (COLESEVELAM HYDROCHLORIDE) is a bile acids sequestering agent. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for colesevelam hydrochloride?
COLESEVELAM HYDROCHLORIDE is a marketed brand name for colesevelam hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of colesevelam hydrochloride?
colesevelam hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.